Compound 2039
Identifiers
- Canonical SMILES:
CCC(=O)N1C(C)CN(C(=O)c2ccco2)c2cc(ccc12)-c1ccc(cc1)S(C)(=O)=O
- IUPAC name:
1-[4-(furan-2-carbonyl)-6-(4-methanesulfonylphenyl)-2-methyl-1,2,3,4-tetrahydroquinoxalin-1-yl]propan-1-one
- InChi:
InChI=1S/C24H24N2O5S/c1-4-23(27)26-16(2)15-25(24(28)22-6-5-13-31-22)21-14-18(9-12-20(21)26)17-7-10-19(11-8-17)32(3,29)30/h5-14,16H,4,15H2,1-3H3
- InChiKey:
QKPQTHQXGQUXRX-UHFFFAOYSA-N
External links
![]() 146340782 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 1 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
Bromodomain / Histone | 6.26 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 452.14 g/mol | |||
HBA | 7 | |||
HBD | 0 | |||
HBA + HBD | 7 | |||
AlogP | 2.52 | |||
TPSA | 87.90 | |||
RB | 4 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 1 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
10.1021/acsmedchemlett.7b00191 | compound 12 | BRD4 Q9ESU6 |
H33 P84243 |
Biochemical assay | alphascreen BRD4 | pIC50 (half maximal inhibitory concentration, -log10) | 5.85 | |
10.1021/acsmedchemlett.7b00191 | compound 12 | BRD4 Q9ESU6 |
H33 P84243 |
Cellular assay | cellular viability MV4-11 | MV4-11 | pIC50 (half maximal inhibitory concentration, -log10) | 6.26 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.5272 | 5-CYANO-FURAN-2-CARBOXYLIC ACID [5-HYDROXYMETHYL-2-(4-METHYL-PIPERIDIN-1-YL)-PHENYL]-AMIDE | DB07167 | |
0.5193 | 5-bromo-N-(3-chloro-2-(4-(prop-2-ynyl)piperazin-1-yl)phenyl)furan-2-carboxamide | DB08021 | |
0.5000 | N-{3-[5-(1H-1,2,4-triazol-3-yl)-1H-indazol-3-yl]phenyl}furan-2-carboxamide | DB07020 | |
0.4656 | Furosemide | DB00695 | |
0.4400 | N-[(2S)-4-Methyl-1-oxo-1-{[(4S)-3-oxo-1-(2-pyridinylsulfonyl)-4-azepanyl]amino}-2-pentanyl]-1-benzofuran-2-carboxamide | DB03642 | |
0.4380 | Relacatib | DB06367 | |
0.4363 | Bradanicline | DB06090 | |
0.4249 | Vismodegib | DB08828 | |
0.4236 | AZD-7295 | DB12724 | |
0.4208 | 4-[(3-CHLORO-4-{[(2R)-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPANOYL]AMINO}PHENYL)SULFONYL]-N,N-DIMETHYLBENZAMIDE | DB07403 | |
0.4208 | Bentiromide | DB00522 | |
0.4176 | Dibenzepin | DB13225 | |
0.4167 | Vesnarinone | DB12082 | |
0.4149 | Delparantag | DB12955 | |
0.4124 | Darexaban | DB12289 |